tiprankstipranks
Advertisement
Advertisement

AU:COV Stock Latest News

Cleo Diagnostics Begins Analytical Validation Ahead of Planned FDA 510(k) Bid
Company AnnouncementsCleo Diagnostics Begins Analytical Validation Ahead of Planned FDA 510(k) Bid
10d ago
COV
CLEO Diagnostics Director Restructures Holding of Unlisted Options
PremiumCompany Announcements
CLEO Diagnostics Director Restructures Holding of Unlisted Options
16d ago
COV
Cleo Diagnostics Issues 250,000 New Shares Under Corporations Act Exemption
PremiumCompany Announcements
Cleo Diagnostics Issues 250,000 New Shares Under Corporations Act Exemption
2M ago
COV
CLEO Diagnostics Seeks Quotation for Additional ASX Shares
PremiumCompany Announcements
CLEO Diagnostics Seeks Quotation for Additional ASX Shares
2M ago
COV
Cleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
PremiumCompany Announcements
Cleo Diagnostics Hits Key U.S. Trial Milestone and Locks In Platform for Ovarian Cancer Test
3M ago
COV
Cleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
PremiumCompany AnnouncementsCleo Diagnostics Starts Staged Manufacturing of Ovarian Cancer Test Kits with Bio-Techne
3M ago
COV
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
Premium
Company Announcements
Cleo Diagnostics Hits Key U.S. Trial Milestone for Ovarian Cancer Test
4M ago
COV
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
Premium
Company Announcements
Cleo Diagnostics Finalises Enhanced Biomarker Panel Ahead of FDA Push
4M ago
COV
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
PremiumCompany Announcements
Cleo Diagnostics Narrows Asset Gap as Loss Widens on Lower Revenue
5M ago
COV
Cleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
PremiumCompany Announcements
Cleo Diagnostics Expands U.S. Ovarian Cancer Market Opportunity as Trial Nears Key Milestone
6M ago
COV
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
PremiumCompany Announcements
Hudson Institute Investment Holdings Ceases to Be Substantial Holder in CLEO Diagnostics
7M ago
COV
Cleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
PremiumCompany Announcements
Cleo Diagnostics Flags Pivotal 2026 After Key Progress on Ovarian Cancer Test
7M ago
COV
Cleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
PremiumCompany AnnouncementsCleo Diagnostics Issues Over 8.3 Million New Shares Without Prospectus
7M ago
COV
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
Premium
Company Announcements
CLEO Diagnostics Issues 833,333 Unquoted Options Under Existing Capital Plan
7M ago
COV
CLEO Diagnostics Seeks ASX Quotation for Additional Ordinary Shares
Premium
Company Announcements
CLEO Diagnostics Seeks ASX Quotation for Additional Ordinary Shares
7M ago
COV
CLEO Diagnostics Seeks ASX Quotation for 8.3 Million New Shares
PremiumCompany Announcements
CLEO Diagnostics Seeks ASX Quotation for 8.3 Million New Shares
7M ago
COV
CLEO Diagnostics Ltd Announces Proposed Securities Issuance
PremiumCompany Announcements
CLEO Diagnostics Ltd Announces Proposed Securities Issuance
7M ago
COV
Cleo Diagnostics Secures $5M for U.S. Launch and Screening Development
PremiumCompany Announcements
Cleo Diagnostics Secures $5M for U.S. Launch and Screening Development
7M ago
COV
Cleo Diagnostics Ltd Initiates Trading Halt Ahead of Major Announcement
PremiumCompany Announcements
Cleo Diagnostics Ltd Initiates Trading Halt Ahead of Major Announcement
7M ago
COV
Cleo Diagnostics Secures $1.7M R&D Refund, Strengthening Financial Position for U.S. Market Entry
PremiumCompany AnnouncementsCleo Diagnostics Secures $1.7M R&D Refund, Strengthening Financial Position for U.S. Market Entry
8M ago
COV
Cleo Diagnostics Ltd Reports Successful AGM Outcomes
Premium
Company Announcements
Cleo Diagnostics Ltd Reports Successful AGM Outcomes
8M ago
COV
Cleo Diagnostics Appoints Key Opinion Leader for U.S. Market Entry
Premium
Company Announcements
Cleo Diagnostics Appoints Key Opinion Leader for U.S. Market Entry
8M ago
COV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >